Registration
Conference Brochure
Member Log In
Send To A Friend
Related Events
2009 Cell Based Assays and Bioanalytical Method Development Event 2009October 05 - October 07 2009
Find another IIR Event
Customer Service
Customer Service representatives are available to help from 8 AM - 6 PM EST
Call 888-670-8200
------------------------------------
Need Technical Assistance With this Website?
Send an email to IIR's Web Department
Add Event To Calendar
Agenda at a Glance
Agenda at a Glance
Workshops | Symposium | Day One | Day Two
| Monday, October 5, 2009 | Workshops & Symposium |
|
| ||||||||||||||||||||||||||||
Back to top
FULL DAY SYMPOSIUM
B3 | DEVELOPMENT, VALIDATION AND ASSESSMENT OF RELATIVE POTENCY IN CELL-BASED BIOASSAYS | ||
| 8:00 | Workshop Registration & Morning Coffee | ||
| 9:00 | Chairpersons Opening Remarks Xu-Rong Jiang, PhD, MD, Associate Director, Analytical Biochemistry, MEDIMMUNE | ||
| 9:15 | Development And Selection Of Potency Methods Max L. Tejada, Scientist, GENENTECH | ||
| 9:45 | Cell-Based Functional Potency Assays For Antibodies Blocking TNF-Super Family Ligand Stimulation Judy Young, Scientist, Technology, GENENTECH | ||
| 10:30 | 30-Minute Networking Break | ||
| 11:00 | Flow Cytometry For Potency Assays And Cell Based Assays Harald Kropshofer, Pharmaceutical Research, F. HOFFMANN-LA ROCHE | ||
| 12:00 | Luncheon for Presenters and Workshop Attendees | ||
| 1:30 | Development Of A New Robust Cell-Based Assay For The Characterization Of A Humanized Monoclonal Antibody Fengrong Zuo, PhD, Scientist Biological Technologies, Quality Bioanalytical Development Process Research and Development, GENENTECH | ||
| 2:30 | 30-Minute Afternoon Break | ||
| 3:00 | ROUNDTABLE SESSION Best Practices For Overcoming Potency Assays Challenges Table leaders Xu-Rong Jiang, PhD, MD, Associate Director, Analytical Biochemistry, MEDIMMUNE | ||
| 4:30 | Workshop Concludes | ||
Back to top
| Tuesday, October 6, 2009 | General Session Day 1 |
| 7:00 | Conference Registration and Morning Coffee |
| 8:15 | Chairpersons’ Welcome And Opening Remarks Eric Wakshull, PhD, Senior Scientist/Group Leader, BioAnalytical Research & Development, GENENTECH |
| 8:30 | Equilibrium Modeling And Assays Development Strategies For Measurement Of Free Total And Bound Drug Or Target Lindsay King, PhD, Principal Scientist, PDM Regulated Biotherapeutics, PFIZER |
| 9:15 | Challenges In Bioanalytical Development For Assays Having Subject Specific Matrix Interference Robert Dodge, PhD, Laboratory Director, Immunochemistry and Cell Biology, PHARMANET |
| 10:00 | 30-minute Morning Networking Break |
| 10:30 | Comparative Analysis Of Results Obtained In Various Assays Used In Support Of Antibody-Drug Conjugate Projects Boris Gorovits, PhD, Director, BioAnalytical, WYETH |
| 11:15 | Challenges And Solutions For Developing Elisa Assays For Antibody-Drug Conjugates Katherine Kozak, PhD, Scientist (Technology), Assay & Automation Technology, GENENTECH |
| 12:00 | Panel Discussion Antibody-Drug Conjugates - Bioanalytical Strategies To Implement In Your Lab |
| 12:30 | Networking Lunch |
| 1:30 | Resolving Heterophilic Antibody Interference In Biomarker Assays Laura DeForge, PhD, Senior Scientist, Assay & Automation Technology, GENENTECH |
| 2:15 | Bioanalytical Challenges Of Enzyme Therapeutics: From Assay Development To Clinical Correlations Erik Foehr, Director, BioAnalytical Research and Development, BIOMARIN PHARMACEUTICALS |
| 3:00 | 30-Minute Afternoon Networking Break |
| 3:30 | Qualification Of Sensitive Assays For The Detection And Quantitation Of Protective Antigen (Pa) In Animals Challenged With B. Anthracis Thi Migone, PhD, Senior Director, Clinical Immunology, HUMAN GENOME SCIENCES |
| 4:15 | Utilizing A Novel Bioanalytical Reagent To Overcome Interference Challenges In Sle Patient Sera Alyssa Morimoto, PhD, Scientist, BioAnalytical Research and Development, GENENTECH |
| 5:00 | Day 1 Concludes |
| 6:00 | Dine-Arounds And The Berkeley Experience * Cost of Dine-Arounds not included in conference registration price |
Back to top
| Wednesday, October 7, 2009 | General Session Day 2 |
| 8:00 | Conference Registration and Morning Coffee |
| 8:15 | Chairpersons’Recap of Day One Eric Wakshull, PhD, Senior Scientist/Group Leader, BioAnalytical Research & Development, GENENTECH |
| 8:30 | FC FUNCTIONALITY Application Of An Fc Gamma Receptor Iiia Binding Assay In Assessment Of Fc Structure And Functionalities Yucai Peng, PhD, Scientist II, BIOGEN IDEC |
| 9:15 | Measuring Binding Of Antibody To Fcg Receptor Iii: Comparison Of Soluble Fc Receptor Elisas And Cell-Based Binding Assays Yanmei Lu, Associate Scientist, Assay & Automation Technology, GENENTECH |
| 10:00 | 15 Minute Networking Break |
| 10:15 | Mouse Models For Ab Therapy Of B-Cell Lymphoma M. Jules Mattes, formerly Associate Member, CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY |
| 11:00 | A Generic Method For Screening Antibody To Fc Receptor Binding By Spr Relating To Adcc Function Rosie Wong PhD, Principal Scientist, Analytical Development, MEDAREX |
| 11:45 | Panel Discussion Assessment of Fc Functionality Panelists: Yucai Peng, PhD, Scientist II, BIOGEN IDEC |
| 12:30 | Conference Concludes |
Home Register Brochure Send to a Colleague
© 2009 IIR USA, LTD. All Rights Reserved.